Medicaid prescription drug spending increased by 47% from FY 2017 to FY 2022, rising from $29.8 billion to $43.8 billion, despite drug usage remaining below 2017 levels. Rebates reduced net Medicaid spending to about half, favoring brand over generic drugs. Despite Medicaid enrollment reaching historic levels during the pandemic, prescription drug usage remained low. States continue to take measures to reduce rising prescription drug costs, with over two-thirds implementing new initiatives focused on drug cost containment. However, the potential cancellation of pandemic continuous enrollment provisions could further impact spending and usage trends.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
